http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107648235-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
filingDate | 2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107648235-B |
titleOfInvention | Application of ponatinib in preparation of medicine for treating ischemia/reperfusion injury |
abstract | The invention discloses an application of ponatinib in preparation of a medicine for treating ischemia/reperfusion injury. The ponatinib is used for treating ischemia/reperfusion injury, particularly treating brain tissue neuropathy, more particularly has a protective effect on ischemic stroke, and can remarkably relieve the cerebral ischemia/reperfusion injury. |
priorityDate | 2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.